Skip Navigation Links

Ajay Goel, Ph.D.

 

      

 

Ajay Goel, Ph.D. Director  

 

Investigator/Professor

Director, Center for Gastrointestinal Research

Director, Center for Epigenetics, Cancer Prevention and Cancer

Genomics

Baylor Research Institute and Charles A Sammons Cancer

Center, Baylor University Medical Center, Dallas, TX

 

E-mail: Ajay.Goel@baylorhealth.edu

 

Contact Information: 

214-820-6852 (Phone)      

214-818-9292 (Fax)

 

 

Education and Training:

B.S (Honors): 1985; Biophysics, Panjab University, Chandigarh, India

M.S. (Honors): 1988; Biophysics, Panjab University, Chandigarh, India

Ph.D.: 1996; Biophysics, Panjab University, Chandigarh, India.

Post-doctoral fellowship: 1996-98; Department of Biophysics and Physiology, University of Virginia, Charlottesville, VA

Post-Doctoral fellowship: 1998-2001; Department of Medicine, University of California San Diego, La Jolla, CA

 

Research Interests:

  • The genetics and epigenetic basis of gastrointestinal cancers
  • Familial cancers and polyposis syndromes
  • Cancer epigenetics, including the role of DNA methylation and histone modifications
  • Noncoding RNAs, particularly microRNAs and their role in cancer pathogenesis
  • Molecular pathology and diagnostics for gastrointestinal cancers
  • Prognostic and predictive biomarkers for gastrointestinal cancers
  • Cancer disparities among different racial/ethnic populations
  • Personalized medicine for gastrointestinal cancers
  • Chemoprevention, using complementary and alternative approaches
  • Familial cancers and polyposis syndromes
  • Cancer epigenetics, including the role of DNA methylation and histone modifications

 

Current Research:

I have a long-standing interest in understanding the pathogenesis of colorectal cancer, and develop strategies for its primary and secondary prevention. Currently, one of the primary focuses of my research program is cancer prevention through development of robust molecular biomarkers that can facilitate early diagnosis, better prognosis or predict response to chemotherapies for human cancer, particularly colorectal cancer. Currently our research program is funded by grants from the National Cancer Institute, Institutional support and several grants from the Baylor Sammons Cancer Center. 

 

Publications:

http://www.ncbi.nlm.nih.gov/pubmed/?term=Ajay+Goel



Copyright © 2015 Baylor Scott & White Health All Rights Reserved.   |   3500 Gaston Avenue, Dallas, TX 75246-2017   |   1.800.9BAYLOR
Site Map   |   Privacy Terms & Patient Rights   |   Terms of Use